Catalyst Wire Dossier Catalyst Wire Dossier

CVT-E002

· CV Technologies
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CVT-E002, covering 2007-06-18 to 2012-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population [Phase 2]

See pricing